Business
SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved
About this update from Sanuwave Health, Inc.
[{"type":"text","content":" EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--\nSANUWAVE Health, Inc. (the \"Company\" or \"SANUWAVE”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 21, 2025, at 8:30 AM (ET) to present its Q4 and Full Year 2024 financial results.\n\nTelephone access to the call will be available by dialing the following numbers:\n\nParticipant Dial-in Information\n\nToll Free: 1-800-245-3047\n\nToll/International: 1-203-518-9765\n\nConference ID: SANUWAVE\n\nOR click the link for instant telephone access to the event: https://viavid.webcasts.com/starthere.jsp?ei=1703280&tp_key=c099e4f4d9\n\nMaterials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.\n\nA replay will be made available through April 11, 2025:\n\nToll-Free: 1-844-512-2921 or 1-412-317-6671\n\nReplay Access ID: 11157832\n\nAbout SANUWAVE\n\nSANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.\n\nSANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.\n\nForward-Looking Statements\n\nThis press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect ope...